Edition:
United States

NantHealth Inc (NH.OQ)

NH.OQ on NASDAQ Stock Exchange Global Select Market

3.13USD
23 Feb 2018
Change (% chg)

$0.04 (+1.29%)
Prev Close
$3.09
Open
$3.09
Day's High
$3.17
Day's Low
$2.99
Volume
27,931
Avg. Vol
50,978
52-wk High
$7.80
52-wk Low
$2.60

Latest Key Developments (Source: Significant Developments)

NantHealth reports 2017 third quarter financial results
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - Nanthealth Inc :NantHealth reports 2017 third quarter financial results; GPS revenue doubles from preceding quarter.Q3 adjusted non-GAAP loss per share $0.13 from continuing operations.Q3 loss per share $0.20 from continuing operations.Q3 loss per share $0.37.Q3 revenue $21.8 million versus $20.7 million.Q3 revenue view $29.2 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $-0.13 -- Thomson Reuters I/B/E/S.NantHealth Inc - ‍ restructuring plan was initiated in Q3, plan expected to generate annualized cost savings of more than $70 million​.  Full Article

NantHealth reports Q2 loss per share $0.58
Thursday, 10 Aug 2017 04:15pm EDT 

Aug 10 (Reuters) - NantHealth Inc -:NantHealth reports 2017 second quarter financial results; implements plan to focus on core competencies, enhance profitability and position for growth of artificial intelligence for cancer care.Q2 adjusted non-gaap loss per share $0.18.Q2 loss per share $0.58.Q2 revenue $26.2 million versus i/b/e/s view $31.3 million.Q2 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S.  Full Article

Nanthealth says GPS cancer is now covered by Sistemas Medicos Nacionales
Monday, 7 Aug 2017 10:29am EDT 

Aug 7 (Reuters) - Nanthealth Inc :GPS cancer is now covered by Sistemas Medicos Nacionales.  Full Article

Nanthealth Inc - ‍Blue Cross and Blue Shield of Nebraska has signed a three-year contract extension for NaviNet Open​
Tuesday, 1 Aug 2017 08:00am EDT 

Aug 1 (Reuters) - Nanthealth Inc :Nanthealth Inc - ‍Blue Cross and Blue Shield of Nebraska has signed a three-year contract extension for NaviNet Open​.  Full Article

Nanthealth Q1 adjusted non-gaap loss per share $0.24
Wednesday, 10 May 2017 04:15pm EDT 

May 10 (Reuters) - Nanthealth Inc ::Nanthealth reports 16% increase in 2017 first quarter total net revenue; saas revenue rose 11% and gps adoption continues to climb.Q1 adjusted non-gaap loss per share $0.24.Q1 loss per share $0.34.Q1 revenue rose 16 percent to $22.5 million.Q1 revenue view $29.1 million -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S.  Full Article

Nanthealth posts Q4 adj. loss per share $0.18
Thursday, 30 Mar 2017 04:23pm EDT 

Nanthealth Inc : Nanthealth reports 72 pct increase in full year 2016 total net revenue to $100 million with saas revenue increasing more than 181 pct and increasing GPS cancer adoption . Q4 adjusted non-GAAP loss per share $0.18 . Q4 loss per share $0.49 . Q4 revenue $24.1 million versus I/B/E/S view $27.9 million .Q4 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S.  Full Article

NantHealth announces pricing of $100 mln of 5.50 pct convertible notes
Friday, 16 Dec 2016 08:00am EST 

NantHealth Inc - : Pricing of an aggregate of $100 million principal amount of 5.50% convertible senior notes due 2021 . Estimates that aggregate net proceeds from offerings will be approximately $96.2 million .NantHealth Inc announces pricing of $100 million of 5.50 pct convertible notes.  Full Article

NantHealth, NantKwest and NantOmics announce availability of GPS cancer and phase i - iii quilt trials through the U.S. National Institutes of Health's ClinicalTrials.gov
Thursday, 8 Dec 2016 08:00am EST 

NantHealth Inc :NantHealth, NantKwest and NantOmics announce availability of GPS cancer and phase i - iii quilt trials through the U.S. National Institutes of Health's ClinicalTrials.gov.  Full Article

NantHealth enters into reseller agreement with Lunatus
Monday, 5 Dec 2016 10:05am EST 

NantHealth Inc : Entered into an exclusive reseller agreement for GPS cancer advanced molecular analysis with Lunatus .Under terms of agreement, Lunatus will have exclusive rights to distribute GPS cancer to physicians in Middle East.  Full Article

Nanthealth reports strong 2016 Q2 revenues and continued progress on GPS Cancer and nantos platform
Tuesday, 9 Aug 2016 04:15pm EDT 

Nanthealth Reports Strong 2016 Second : Q2 adjusted non-GAAP loss per share $0.15 . Q2 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S . Q2 loss per share $0.52 . Quarter revenues and continued progress on GPS Cancer and nantos platform . Q2 revenue rose 167 percent to $31.5 million .Q2 revenue view $23.5 million -- Thomson Reuters I/B/E/S.  Full Article

RPT-UPDATE 3-Tronc to sell LA Times, other newspapers for $500 mln

Feb 7 Tronc Inc said on Wednesday it agreed to sell the Los Angeles Times, the San Diego Union-Tribune and some other newspapers to billionaire investor Patrick Soon-Shiong for $500 million cash.